SCHEMBL25281112

SCHEMBL25281112

CC1=CN(C(=O)OCOC(=O)c2ccccc2)CC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.43
LMNA P02545 1/20 0.42
CHRNB2 P17787 1/20 0.41
CHRNA5 P30532 1/20 0.41
CHRNA7 P36544 1/20 0.41
CHRNA4 P43681 1/20 0.41
TDP1 Q9NUW8 2/20 0.41
NPC1 O15118 4/20 0.40
RAB9A P51151 4/20 0.40
KMT2A Q03164 3/20 0.40
MEN1 O00255 2/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
TSHR P16473 1/20 0.40
MAPK1 P28482 1/20 0.40
HIF1A Q16665 1/20 0.40
SLC6A2 P23975 1/20 0.40
SLC6A3 Q01959 1/20 0.40
ALDH1A1 P00352 1/20 0.39
SMN1; SMN2 Q16637 3/20 0.38
GAA P10253 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28875175 0.73 TDP1 (0.68) LMNATDP1NPC1RAB9AKMT2A
SCHEMBL51601 0.73 TDP1 (0.68) LMNATDP1NPC1RAB9AKMT2A
SCHEMBL11210177 0.70 ALDH1A1 (0.49) MAPTLMNATDP1KMT2AMEN1
SCHEMBL2652364 0.69 LMNA (0.58) LMNATDP1NPC1RAB9AKMT2A
Ethylene Glycol SCHEMBL15661698 0.69 ALDH1A1 (0.62) LMNATDP1NPC1RAB9AKMT2A
SCHEMBL25233109 0.68 CHRNB2 (0.45) MAPTLMNACHRNB2CHRNA5CHRNA7
SCHEMBL18862636 0.68 MAPK1 (0.55) MAPTLMNATDP1NPC1RAB9A
SCHEMBL514540 0.67 LMNA (0.60) LMNATDP1NPC1RAB9AKMT2A
SCHEMBL9817384 0.67 TDP1 (0.59) LMNATDP1NPC1RAB9AKMT2A
SCHEMBL4570317 0.67 TDP1 (0.59) MAPTLMNATDP1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023114200-A2 METHODS FOR THE SYNTHESIS OF COMPLEMENT FACTOR D INHIBITORS AND INTERMEDIATES THEREOF ALEXION PHARMACEUTICALS, INC. (US) 2023-06-22 WO disclosed